ZOTA Zota Health Care Q1 FY27 results (Apr–Jun 2026) and concall
Zota Health Care Limited delivered strong Q1 FY27 results with significant revenue growth and improved gross margins, driven by continued Davaindia network expansion. While increased marketing investments and temporary input cost pressures impacted profitability, management is confident in returning to reported EBITDA positivity next quarter and achieving cash breakeven by Q4 FY27 or Q1 FY28. The company also outlined a clear strategy for store maturity and market penetration.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 62.8%, net profit down 67.8% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 59 | 68 | 78 | 78 | 99 +68% | 109 +60% | 121 +55% | 127 +63% |
| EBITDA | 3 | 1 | 4 | 7 | 11 +233% | 8 +531% | 5 +36% | 0 −97% |
| Net profit | 2 | 2 | 3 | 6 | 10 +322% | 6 +189% | 6 +134% | 2 −68% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





